Apomorphine for the acute treatment of “off” episodes in Parkinson's disease
Authors:
- Mark StacyMSMark Stacy
- Dee SilverDSDee Silver
- 1 March 2008
- journal article
- review article
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 14 (2) , 85-92
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Efficacy and Tolerability of a Novel Sublingual Apomorphine Preparation in Patients with Fluctuating Parkinsonʼs DiseaseClinical Neuropharmacology, 1999
- Using Liquid Levodopa in the Treatment of Parkinson??s DiseaseDrugs & Aging, 1997
- Comparison of Subcutaneous Apomorphine Versus Dispersible Madopar Latency and Effect Duration in Parkinsonʼs Disease PatientsClinical Neuropharmacology, 1997
- Levodopa ethylester : A novel rescue therapy for response fluctuations in parkinson's diseaseAnnals of Neurology, 1996
- Pen injected apomorphine against off phenomena in late Parkinson's disease: a double blind, placebo controlled study.Journal of Neurology, Neurosurgery & Psychiatry, 1995
- Apomorphine in treatment of Parkinson's disease: comparison between subcutaneous and sublingual routes.Journal of Neurology, Neurosurgery & Psychiatry, 1993
- Sublingual Apomorphine in the Treatment of Parkinsonʼs Disease Complicated by Motor FluctuationsClinical Neuropharmacology, 1991
- The Clinical Efficacy of Oral Levodopa Methyl Ester Solution in Reversing Afternoon “Off” Periods in Parkinsonʼs DiseaseClinical Neuropharmacology, 1991
- Efficacy of sublingual apomorphine in Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1990
- SUBCUTANEOUS APOMORPHINE IN PARKINSON'S DISEASEThe Lancet, 1988